SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-010484
Filing Date
2022-05-02
Accepted
2022-05-02 16:56:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A urgn20220428_defa14a.htm DEFA14A 8834
2 proxycardpg1.jpg GRAPHIC 152307
3 proxycardpg2.jpg GRAPHIC 118072
  Complete submission text file 0001437749-22-010484.txt   371450
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38079 | Film No.: 22882880
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences